8-K: Kewaunee Scientific Reports Strong Sales Growth, Impacted by Nu Aire Acquisition Costs in Q3 Fiscal Year 2025

Kewaunee Scientific Corporation announces a 43.6% increase in sales for Q3 2025, but pre-tax earnings decreased due to acquisition and integration costs related to Nu Aire.

Summary

• Kewaunee Scientific Corporation reported its Q3 fiscal year 2025 results, showing a significant increase in sales but a decrease in pre-tax earnings.
• Sales for the quarter reached $67.167 million, a 43.6% increase compared to $46.778 million in the prior year's quarter.
• Pre-tax earnings decreased by 63.7% to $1.275 million, compared to $3.515 million in the same quarter last year.
• Net earnings were $1.354 million, down from $2.521 million in the prior year quarter.
• Diluted earnings per share were $0.45, compared to $0.85 in the prior year quarter.
• The results were impacted by costs associated with the acquisition and integration of Nu Aire, as well as transaction accounting related to the write-up of assets.
• Adjusted for these costs, pre-tax earnings increased by 7.8% to $3.789 million, and adjusted EBITDA increased to $5.728 million.
• The company's order backlog was $221.6 million on January 31, 2025, compared to $152.3 million on January 31, 2024.
• The acquisition of Nu Aire was completed on November 1, 2024, and its financial results are now integrated into Kewaunee's Domestic segment.
• Domestic sales increased by 63.6% to $51.976 million, while international sales increased by 1.2% to $15.191 million.
• Total cash on hand was $12.335 million, and long-term debt was $65.819 million, including $27.604 million from a sale-leaseback transaction.

Sentiment

Score: 6

Explanation: The sentiment is moderately positive due to strong sales growth and a large backlog, but tempered by decreased earnings and acquisition-related costs. The management expresses confidence in future performance.

Positives

• Sales increased significantly by 43.6% to $67.167 million.
• The order backlog is strong at $221.6 million.
• The Nu Aire acquisition was successfully completed and is contributing to domestic sales growth.
• Adjusted pre-tax earnings and EBITDA show improvement when excluding acquisition-related costs.
• Domestic sales experienced substantial growth, driven by increased manufacturing volumes and the Nu Aire acquisition.

Negatives

• Pre-tax earnings decreased by 63.7% to $1.275 million due to acquisition and integration costs.
• Net earnings decreased to $1.354 million from $2.521 million in the prior year quarter.
• Diluted earnings per share decreased to $0.45 from $0.85 in the prior year quarter.
• International segment net earnings and EBITDA decreased due to customer site delays.
• Corporate segment net loss and EBITDA worsened due to acquisition-related fees and Sarbanes-Oxley compliance costs.

Risks

• The company faces risks related to the integration of Nu Aire and realizing the anticipated benefits.
• Fluctuations in operating results from quarter to quarter could impact financial performance.
• International operations are subject to foreign currency fluctuations and customer site delays.
• Changes in raw materials and commodity costs could affect profitability.
• The company is exposed to risks related to competitive and general economic conditions, including supply chain disruptions.

Future Outlook

The company is focused on delivering a strong finish to fiscal year 2025 and continues to invest in partnerships to support channel partners and drive sustainable growth.

Management Comments

• 'Kewaunee delivered another strong quarter, demonstrating once again our positive momentum in the marketplace and our continued operational performance improvement,' said Thomas D. Hull III, Kewaunee's President and Chief Executive Officer.
• 'Our strategy to emphasize investments in our manufacturing assets, while strengthening our dealer and distribution relationships is working.'
• Hull stated that revenue in India has been slowed due to construction site delays but expects favorable revenue and earnings when project sites are ready.
• Hull highlighted the strength and diversity of the markets Kewaunee serves and the company's ability to meet evolving customer needs.

Industry Context

Kewaunee operates in the laboratory, healthcare, and technical furniture industry, serving critical sectors like life sciences, healthcare, and education, which benefit from long-term structural growth trends. The acquisition of Nu Aire expands Kewaunee's product portfolio and strengthens its position as a comprehensive provider of laboratory solutions.

Comparison to Industry Standards

• It is difficult to provide a direct comparison to industry standards without specific competitor data.
• However, companies like Steelcase and Herman Miller also operate in related furniture and workspace solutions markets.
• Kewaunee's focus on laboratory and technical furniture provides a niche specialization.
• The 43.6% sales increase is significant, but the impact of acquisition costs needs to be considered in the overall financial performance.
• The backlog increase suggests strong future demand, which is a positive indicator compared to industry averages.

Stakeholder Impact

• Shareholders may be concerned about the decrease in earnings, but encouraged by the sales growth and backlog.
• Employees may benefit from the company's growth and expansion.
• Customers will have access to a broader range of products and solutions through the Nu Aire acquisition.
• Suppliers may see increased demand due to the company's growth.
• Creditors should monitor the company's debt levels and financial performance.

Next Steps

• The company will focus on delivering a strong finish to fiscal year 2025.
• Kewaunee will continue to invest in partnerships and support channel partners.
• The company will work closely with customers in India to ensure seamless execution of projects when construction sites are ready.

Key Dates